The US Treasury announced it will double its buybacks of long-term debt from $2 billion to at least $4 billion to counter a recent selloff that pushed yields to uncomfortable levels. This move aims to lower the 10-year Treasury yield and ease borrowing costs, but critics warn it could fuel inflation, increase reliance on short-term debt, and pressure the Federal Reserve to support fiscal policy. The Treasury's strategy involves replacing long-term bonds with short-term bills, which may raise the government's sensitivity to interest rate changes and complicate the Fed's inflation control efforts. The situation highlights tensions between Treasury Secretary Scott Bessent's efforts and Fed Chairman Kevin Warsh's goals, with upcoming discussions expected at the Jackson Hole symposium.
The Hershey Trust Company sold 1,512 common shares under a trading plan but kept voting control through Class B shares. Hershey will report Q3 earnings on October 29, with investors focused on how price increases affected Halloween-season demand. Q2 ...
W. R. Berkley reported mixed Q3 2026 results with earnings per share of $1.17 beating estimates, but revenue fell short at $3.74 billion versus $3.82 billion expected. The company saw premium growth with gross premiums up 3% and net premiums up 1%, s...
GE Aerospace is set to report its Q3 earnings with analysts forecasting a 21.7% rise in earnings per share to $2.02 and nearly 12% revenue growth to about $12.7 billion. Despite consistently beating estimates, the stock has fallen after past reports ...
Silence Therapeutics' stock surged 125.6% to $19.58 following Merck KGaA's agreement to acquire the RNA-interference drug developer for about $1.3 billion in equity value. Merck will pay $20 per share, a 130% premium over the recent closing price. Ot...
On October 19, 2026, several stocks saw significant declines. Iambic Therapeutics dropped 31.4% but stayed just above its IPO price of $16 after raising $150 million. TCGX Acquisition fell 18.5% following its announcement of a merger with TriGemX Bio...
